Form 8-K - Current report:
SEC Accession No. 0000950170-25-045250
Filing Date
2025-03-26
Accepted
2025-03-26 16:16:15
Documents
12
Period of Report
2025-03-26
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K drrx-20250326.htm   iXBRL 8-K 49501
2 EX-99.1 drrx-ex99_1.htm EX-99.1 357847
  Complete submission text file 0000950170-25-045250.txt   542878

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT drrx-20250326.xsd EX-101.SCH 29456
14 EXTRACTED XBRL INSTANCE DOCUMENT drrx-20250326_htm.xml XML 4509
Mailing Address 10240 BUBB ROAD CUPERTINO CA 95014
Business Address 10240 BUBB ROAD CUPERTINO CA 95014 4087771417
DURECT CORP (Filer) CIK: 0001082038 (see all company filings)

EIN.: 943297098 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-31615 | Film No.: 25773381
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)